Delivery Order SPE2DE24DA012-SPE2D625F4EPU

Johnson & Johnson Health Care Systems Inc. (Jjhcs), a division of Johnson & Johnson, was awarded a delivery order valued at $37,221.79 on September 25, 2025, for an Attune CRS Femoral Right Size 6 Cement orthopedic implant. The contract is a fixed-price delivery order with economic price adjustment mechanisms and carries an ultimate completion date of September 30, 2025. This award was issued under Jjhcs's larger $86.1 million Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, which runs through July 2029 and covers a comprehensive range of specialized medical supplies and joint procedural packages. No set-aside was used for this award, reflecting Jjhcs's status as a large business prime contractor. The product will be performed from the contractor's facility in Raritan, New Jersey, and is funded through the Medical Supply Chain division of the Department of Defense.

This delivery order represents a continuation of Jjhcs's critical support to the military medical infrastructure, providing advanced orthopedic implants and surgical products to Department of Defense healthcare facilities. The DePuy Synthes joint replacement components, including the Attune CRS femoral implant awarded under this order, are processed electronically through the DLA Troop Support Medical Electronic Catalog system and are supported by on-site technical expertise provided by Jjhcs to military hospitals nationwide. The company's extensive history of delivering sophisticated medical technologies to federal agencies, combined with its single-award IDC status, positions it as a primary supplier of orthopedic implants and surgical instrumentation to the Defense Department.